XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note D - Marketable Equity Securities
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
NOTE D: MARKETABLE EQUITY SECURITIES
The Company accounts for its marketable equity securities in accordance with ASC Topic
321,
(“ASC Topic
321”
),
Investments- Equity Securities
. ASC Topic
321
requires companies to measure equity investments at fair value, with changes in fair value recognized in net income. The Company’s investments in marketable securities consist of equity securities with readily determinable fair values. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (expense).
 
Marketable equity securities are carried at fair value, with gains and losses in fair market value included in the determination of net income. The fair value of marketable equity securities is determined based on quoted market prices in active markets, as described in Note J.
 
The following table sets forth market value, cost, and unrealized gains on equity securities as of
June 30, 2018
and
December 31, 2017. 
 
   
June 30, 2018
   
December 31, 2017
 
   
(in thousands)
 
Fair market value
  $
27,860
    $
26,664
 
Cost
   
20,959
     
16,640
 
Unrealized gain
  $
6,901
    $
10,024
 
 
Prior to the Company’s
January 1, 2018
adoption of ASU
2016
-
01,
unrealized losses in fair market value were presented as a component of Accumulated Other Comprehensive Income in shareholders’ equity, and only realized gains and losses and declines in value judged to be other-than-temporary on available-for-sale securities, were included in the determination of net income. The cost of securities determined to be in an other-than-temporary loss position were required to be presented net of the amount of the other-than-temporary impairment calculated. Subsequent to adoption of ASU
2016
-
01,
cost is
no
longer presented net of other-than-temporary impairment. The
December 31, 2017
cost reflected in the table above was presented net of approximately
$2,314,000
of other-than-temporary impairment.
 
The following table sets forth the gross unrealized gains and losses on the Company’s marketable securities as of
June 30, 2018
and
December 31, 2017.
 
   
June 30, 2018
   
December 31, 2017
 
   
(in thousands)
 
Gross unrealized gains
  $
7,983
    $
10,150
 
Gross unrealized losses
   
1,082
     
126
 
Net unrealized gains
  $
6,901
    $
10,024
 
 
The following table shows the Company’s net realized gains during the
first
six
months of
2018
and
2017
on certain marketable equity securities.
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2018
   
2017
   
2018
   
2017
 
 
 
(in thousands)
 
Realized gain      
Sales proceeds
  $
-
    $
711
    $
-
    $
3,079
 
Cost of securities sold
   
-
     
349
     
-
     
934
 
Realized gain
  $
-
    $
362
    $
-
    $
2,145
 
                                 
Realized gain, net of taxes
  $
-
    $
222
    $
-
    $
1,314
 
 
 
 
For the quarter ended
June 30, 2018,
the Company recognized dividends of approximately
$254,000
in non-operating income in its statements of operations. For the quarter ended
June 30, 2017,
the Company recognized dividends of approximately
$272,000
in non-operating income in its statements of operations.
 
For the
six
months ended
June 30, 2018,
the Company recognized dividends of approximately
$472,000
in non-operating income (expense) in its statements of operations. For the
six
months ended
June 30, 2017,
the Company recognized dividends of approximately
$493,000
in non-operating income (expense) in its statements of operations.
 
The market value of the Company’s equity securities are periodically used as collateral against any outstanding margin account borrowings. As of
June 30, 2018
and
December 31, 2017,
the Company had outstanding borrowings of approximately
$7,504,000
and
$5,903,000,
respectively, under its margin account. Margin account borrowings are used for the purchase of marketable equity securities and as a source of short-term liquidity and are included in Accrued expenses and other liabilities on our balance sheets.
 
During the
second
quarter of
2018,
our marketable equity securities portfolio had a net unrealized pre-tax gain in market value of approximately
$333,000,
which was reported as Non-operating income for the period.